Identification of potential pharmacological chaperones that selectively stabilize mutated Aspartoacylases in Canavan disease
{{output}}
Canavan disease is caused by mutations in the ASPA gene, leading to diminished catalytic activity of aspartoacylase in the brain. Clinical missense mutations are found throughout the enzyme structure, with many of these mutated enzymes having not only decrease... ...
